![Anne Frese](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Anne Frese
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEI PHARMA, INC. | Personalreferent | 22.06.2022 | - |
Karriereverlauf von Anne Frese
Ehemalige bekannte Positionen von Anne Frese
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Artiva Biotherapeutics, Inc.
![]() Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Personalreferent | 01.01.2019 | 01.07.2021 |
BELLICUM PHARMACEUTICALS, INC. | Personalreferent | 01.03.2015 | 01.07.2018 |
Vyripharm Enterprises LLC
![]() Vyripharm Enterprises LLC BiotechnologyHealth Technology Vyripharm Enterprises LLC operates biotechnology company which develops drugs for cancer and metabolic diseases. The company is headquartered in Houston, TX. | Personalreferent | - | - |
Ausbildung von Anne Frese
McGill University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Kanada | 2 |
Operativ
Human Resources Officer | 4 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MEI PHARMA, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Bellicum Pharmaceuticals, Inc.
![]() Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Vyripharm Enterprises LLC
![]() Vyripharm Enterprises LLC BiotechnologyHealth Technology Vyripharm Enterprises LLC operates biotechnology company which develops drugs for cancer and metabolic diseases. The company is headquartered in Houston, TX. | Health Technology |
Artiva Biotherapeutics, Inc.
![]() Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Anne Frese
- Erfahrung